Cancer Vaccine

Pic:getty/oatawa

CureVac acquires Frame Cancer Therapeutics

By Rachel Arthur

CureVac has acquired Frame Cancer Therapeutics: with the German mRNA specialist planning to draw on Frame’s expertise in antigen identification and validation as it develops mRNA cancer vaccines.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers